medical communications and marketing expertise

+ 44 (0)1477 549 652  e:
Pivotal 4pharma Testimonials

Professor Michael Baum Testimonial

< Go back to main testimonial page

“I have known, and worked with Tim Sheldon from AstraZeneca for over 10 years, working on a variety programmes and initiatives. It was as Chairman of the ATAC steering Committee that brought me most contact and knowledge of Tim.

Tim worked very closely with the ATAC Steering committee in the planning and delivery of the many external communications relating to the ATAC trial, including the first data presentations and publications in 2002. Relating to the first ATAC publication in the Lancet, Tim acted as the ‘bridge’ between AstraZeneca and the academic committee, where his tact, diplomacy and negotiation skills ensured the publication met the needs of both parties.

I have also been very impressed with his project management and organisation skills, as demonstrated by the delivery of 2 very successful ATAC investigator meetings in which he was heavily involved. I have also participated in other symposia and events internationally, where Tim has played a central role in organisation and delivery, and I have always found him to give clear briefs and guidance, and to operate with integrity, honesty and enthusiasm.

Tim is setting up his own company Pivotal 4pharma, which will focus on the breast cancer area. Based on my experiences working with him, I would have no hesitation in endorsing the services of Pivotal 4pharma to deliver breast cancer events that involve complex organisations, and where the ability to build relationships with breast cancer opinion leaders is an essential requirement.

Finally I would like to claim Tim as a friend. His warm, friendly and witty companionship in the far flung corners of the world always cheered me up, helped me cope with jet lag and protected me from the over-zealous hospitality of some of our foreign hosts. I know for sure that other “opinion leaders" in the world of breast cancer research and treatment share my opinion, so I have no doubt that his new company will flourish and can deliver as promised."

Professor Michael Baum MD, ChM, FRCS, FRCR (hon)
Professor Emeritus of Surgery and Visiting Professor Medical Humanities,
University College London,
The Clinical Trials Group
Royal Free and UCL Medical School
Centre for Clinical Science and Technology
Clerkenwell Building, Archway Campus
Highgate Hill
N19 5LW
United Kingdom
Pivotal 4pharma provides strategic and tactical medical communications and marketing expertise.